Answers are grounded in this paper and cite their sources.
Cross-sectional study finds hypoalbuminemia significantly increases risk of acute respiratory failure in COPD patients, indicating its potential as a predictive marker.
Background: COPD is a major public health burden and a leading cause of morbidity and mortality. Acute respiratory failure (ARF) is a frequent complication of acute exacerbation of COPD (AECOPD). Hypoalbuminemia, a marker of malnutrition and systemic inammation, may predict adverse outcomes in these patients. Objective: To evaluate serum albumin levels in COPD patients and analyze hypoalbuminemia as an independent predictor of Type II acute respiratory failure. Methods: This cross-sectional observational study included 70 patients admitted with AECOPD to Mandya Institute of Medical Sciences between January and November 2024. Patients with PCO₂ >45 mmHg on ABG were diagnosed with Type II ARF. Serum albumin <3.2 g/dL was dened as hypoalbuminemia. Associations between hypoalbuminemia and ARF were analyzed. Results: Hypoalbuminemia was signicantly associated with ARF. Among patients with hypoalbuminemia, 98% developed ARF, while only 2 did not. Older age, higher PCO₂, and lower serum albumin were all independently associated with the development of ARF. Conclusion: Hypoalbuminemia is a signicant and independent predictor of acute respiratory failure in COPD patients and may be useful for early risk stratication in hospitalized cases.
No takes yet. Share an insight, caveat, or question.
Balekundri et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: